Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Debt Ratio (2019 - 2022)

BioScience Health Innovations has reported Debt Ratio over the past 4 years, most recently at 0.12 for Q2 2022.

  • Quarterly Debt Ratio fell 99.73% to 0.12 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 0.12 through May 2022, down 99.73% year-over-year, with the annual reading at 2.76 for FY2021, 628.89% up from the prior year.
  • Debt Ratio was 0.12 for Q2 2022 at BioScience Health Innovations, down from 0.18 in the prior quarter.
  • Over five years, Debt Ratio peaked at 44.12 in Q2 2021 and troughed at 0.12 in Q2 2022.
  • The 4-year median for Debt Ratio is 0.73 (2019), against an average of 5.6.
  • Year-over-year, Debt Ratio skyrocketed 15667.37% in 2021 and then plummeted 99.73% in 2022.
  • A 4-year view of Debt Ratio shows it stood at 0.76 in 2019, then fell by 7.82% to 0.7 in 2020, then crashed by 74.23% to 0.18 in 2021, then crashed by 34.74% to 0.12 in 2022.
  • Per Business Quant, the three most recent readings for BHIC's Debt Ratio are 0.12 (Q2 2022), 0.18 (Q4 2021), and 2.76 (Q3 2021).